Copyright
©The Author(s) 2019.
World J Cardiol. Oct 26, 2019; 11(10): 221-235
Published online Oct 26, 2019. doi: 10.4330/wjc.v11.i10.221
Published online Oct 26, 2019. doi: 10.4330/wjc.v11.i10.221
Figure 3 Cardiomyocyte differentiation protocol.
Modified from Lian et al[135], 2012. hiPSCs: Human induced pluripotent stem cells.
- Citation: Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: What is the best option? World J Cardiol 2019; 11(10): 221-235
- URL: https://www.wjgnet.com/1949-8462/full/v11/i10/221.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i10.221